High Purity Azithromycin (83905-01-5) Oral Grad GMP Factory
|FOB Price:||US $0.1-100 / Box|
|Min. Order:||100 Boxes|
|Min. Order||FOB Price|
|100 Boxes||US $0.1-100/ Box|
|Payment Terms:||L/C, T/T, D/P, Western Union, Paypal, Money Gram|
- Model NO.: tablets
- Customized: Customized
- Suitable for: Elderly, Children, Adult
- Purity: >98%
- Dosage: 250mg
- Transport Package: Box
- Origin: China
- Powder: No
- Certification: GMP, ISO 9001, USP, BP
- State: Tablet
- Use: Antibiotic
- Trademark: sunbiolab
- Specification: 250
|Shelf Lift||36 month|
|Store||Store below 25oC.Protect from light.|
WE CAN PROVIDE MAKE FORMEULATION (OEM)
Azithromycin is used to treat many different infections, including:
- Prevention and treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease due to H. influenzae, M. catarrhalis, or S. pneumoniae. The benefits of long-term prophylaxis must be weighed on a patient-by-patient basis against the risk of cardiovascular and other adverse effects.
- Acute bacterial sinusitis due to H. influenzae, M. catarrhalis, or S. pneumoniae. Other agents, such as amoxicillin/clavulanate are generally preferred, however.
- Community-acquired pneumonia' due to C. pneumoniae, H. influenzae, M. pneumoniae, or S. pneumoniae
- Acute otitis media caused by H. influenzae, M. catarrhalis or S. pneumoniae. Azithromycin is not, however, a first-line agent for this condition. Amoxicillin or another beta lactam antibiotic is generally preferred.
- Pharyngitis or tonsillitis caused by S. pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy
- Uncomplicated skin and skin structure infections due to S. aureus, S. pyogenes, or S. agalactiae
- Urethritis and cervicitis due to C. trachomatis or N. gonorrhoeae
- Trachoma due to C. trachomatis
- Genital ulcer disease (chancroid) in men due to H. ducreyi
- In combination with ceftriaxone, azithromycin is part of the United States Centers for Disease Control-recommended regimen for the treatment of gonorrhea. Azithromycin is active as monotherapy in most cases, but the combination with ceftriaxone is recommended based on the relatively low barrier to resistance development in gonococci.